DK0789567T3 - En fremgangsmåde til behandling af vaskulære hovedpiner - Google Patents
En fremgangsmåde til behandling af vaskulære hovedpinerInfo
- Publication number
- DK0789567T3 DK0789567T3 DK95942443T DK95942443T DK0789567T3 DK 0789567 T3 DK0789567 T3 DK 0789567T3 DK 95942443 T DK95942443 T DK 95942443T DK 95942443 T DK95942443 T DK 95942443T DK 0789567 T3 DK0789567 T3 DK 0789567T3
- Authority
- DK
- Denmark
- Prior art keywords
- treating vascular
- vascular headaches
- migraine headache
- treating
- headaches
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/342,090 US5767117A (en) | 1994-11-18 | 1994-11-18 | Method for treating vascular headaches |
PCT/US1995/015070 WO1996015782A1 (en) | 1994-11-18 | 1995-11-17 | A method for treating vascular headaches |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0789567T3 true DK0789567T3 (da) | 2007-09-24 |
Family
ID=23340286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95942443T DK0789567T3 (da) | 1994-11-18 | 1995-11-17 | En fremgangsmåde til behandling af vaskulære hovedpiner |
Country Status (10)
Country | Link |
---|---|
US (2) | US5767117A (da) |
EP (2) | EP0789567B1 (da) |
JP (2) | JPH10509178A (da) |
AT (1) | ATE362361T1 (da) |
CA (1) | CA2205134C (da) |
DE (1) | DE69535498T2 (da) |
DK (1) | DK0789567T3 (da) |
ES (1) | ES2289745T3 (da) |
PT (1) | PT789567E (da) |
WO (1) | WO1996015782A1 (da) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI0934061T1 (en) | 1996-07-24 | 2003-10-31 | Warner-Lambert Company Llc | Isobutylgaba and its derivatives for the treatment of pain |
US5914333A (en) * | 1996-07-31 | 1999-06-22 | Novo Nordisk A/S | Treatment of psychotic disorders |
WO1998005337A1 (en) * | 1996-08-01 | 1998-02-12 | Cocensys, Inc. | Use of gaba and nmda receptor ligands for the treatment of migraine headache |
US6787530B1 (en) | 1996-08-23 | 2004-09-07 | Monash University | Use of pregnane-diones as analgesic agents |
WO1998019674A2 (en) * | 1996-11-05 | 1998-05-14 | Head Explorer Aps | A method for treating tension-type headache |
US6284794B1 (en) | 1996-11-05 | 2001-09-04 | Head Explorer Aps | Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase |
EP2332580A1 (en) * | 1998-12-23 | 2011-06-15 | NeuroTherapeutics Pharma, Inc. | A composition for the treatment of the central nervous system |
EP1124416A1 (en) * | 1999-03-15 | 2001-08-22 | John Claude Krusz | Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages |
GB9906130D0 (en) * | 1999-03-18 | 1999-05-12 | Knoll Ag | Compounds for use in therapy |
EP1181012B1 (en) * | 1999-05-04 | 2004-09-15 | Keith R. Edwards | Intravenous valproate for acute treatment of migraine headache |
US6333345B1 (en) * | 1999-05-14 | 2001-12-25 | Sepracor, Inc. | Methods of using and compositions comprising N-desmethylzolpidem |
PT1200073E (pt) * | 1999-07-06 | 2007-03-30 | Lilly Co Eli | Antagonistas selectivos do receptor de iglur5 para o tratamento de enxaqueca |
EP1257545A1 (en) | 1999-12-22 | 2002-11-20 | Eli Lilly And Company | SELECTIVE iGLUR 5? RECEPTOR ANTAGONISTS |
US6362234B1 (en) * | 2000-08-15 | 2002-03-26 | Vyrex Corporation | Water-soluble prodrugs of propofol for treatment of migrane |
US20020072509A1 (en) * | 2000-10-11 | 2002-06-13 | Stein Donald Gerald | Methods for the treatment of a traumatic central nervous system injury |
US6924294B2 (en) * | 2001-01-05 | 2005-08-02 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
US6855725B2 (en) * | 2001-01-05 | 2005-02-15 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
US6953805B2 (en) * | 2001-01-05 | 2005-10-11 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
US7205313B2 (en) * | 2001-01-05 | 2007-04-17 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
ATE415155T1 (de) * | 2001-05-24 | 2008-12-15 | Alexza Pharmaceuticals Inc | Verabreichung von alprazolam, estazolam, midazolam oder triazolam durch inhalation |
US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
CA2446904A1 (en) * | 2001-05-24 | 2003-04-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
US7498019B2 (en) | 2001-05-24 | 2009-03-03 | Alexza Pharmaceuticals, Inc. | Delivery of compounds for the treatment of headache through an inhalation route |
US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
US6759029B2 (en) * | 2001-05-24 | 2004-07-06 | Alexza Molecular Delivery Corporation | Delivery of rizatriptan and zolmitriptan through an inhalation route |
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
US20030051728A1 (en) * | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
JPWO2003006052A1 (ja) * | 2001-07-09 | 2005-02-17 | 山之内製薬株式会社 | 徐放性注射剤用組成物およびその製造方法 |
US20030045541A1 (en) * | 2001-07-23 | 2003-03-06 | Christopher Bruckner | GABA-Receptor modulators with NMDA-Antagonistic activity |
WO2003041693A1 (en) | 2001-11-09 | 2003-05-22 | Alexza Molecular Delivery Corporation | Delivery of diazepam through an inhalation route |
SE0104423D0 (sv) | 2001-12-27 | 2001-12-27 | Umecrine Ab | Pregnane steroids and their use in the treatment of CNS disorders |
WO2003090780A1 (en) * | 2002-04-26 | 2003-11-06 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Direct cell target analysis |
PT1511741E (pt) | 2002-04-26 | 2013-02-05 | Lilly Co Eli | Derivados éster de um ácido deca-hidroisoquinolino-3- carboxílico como analgésicos |
US20040105818A1 (en) | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
WO2004066930A2 (en) * | 2003-01-27 | 2004-08-12 | Arthur Zaks | Method for inducing pain relief using imidazo[1,2-a]pyridine derivatives |
US20040241100A1 (en) * | 2003-03-17 | 2004-12-02 | Fabre Kramer Pharmaceutical, Inc. | Nasally administrable compositions of zolpidem and methods of use |
CA2526475A1 (en) | 2003-05-21 | 2004-12-02 | Alexza Pharmaceuticals, Inc. | Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same |
US7657309B2 (en) * | 2003-05-28 | 2010-02-02 | The Ohio State University | Measuring human heart muscle viability using myocardial electrical impedance |
WO2005000294A1 (en) * | 2003-06-06 | 2005-01-06 | Pharmacia Corporation | Selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders |
US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
EP1836161B1 (en) | 2004-12-22 | 2016-07-20 | BHI Limited Partnership | Methods and compositions for treating amyloid-related diseases |
AU2006226774B2 (en) | 2005-03-24 | 2010-12-02 | Emory University | Methods for the treatment of central nervous system injury via a tapered administration of progesterone |
US7473687B2 (en) * | 2005-03-24 | 2009-01-06 | Emory University | Methods for the treatment of a traumatic central nervous system injury |
US20070087055A1 (en) * | 2005-10-14 | 2007-04-19 | David Jan | Directly compressible extended release alprazolam formulation |
US20070203216A1 (en) * | 2006-02-14 | 2007-08-30 | Bjarke Ebert | Method of treating inflammatory diseases |
PL2089417T3 (pl) | 2006-10-12 | 2015-07-31 | Bhi Lp | Sposoby, związki, kompozycje i nośniki dostarczające kwas 3-amino-1-propanosulfonowy |
US20080139510A1 (en) * | 2006-12-07 | 2008-06-12 | Abe Rose | Treatment of migraine headaches with sublingual amino acids |
US20080216828A1 (en) | 2007-03-09 | 2008-09-11 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
JP5600058B2 (ja) * | 2007-04-11 | 2014-10-01 | ファーマシューティカル プロダクションズ, インコーポレイテッド | メラトニンタブレットならびに調剤及び使用方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US35517A (en) * | 1862-06-10 | Improved sofa, convertible into a table, trunk, cot | ||
JPS6019713A (ja) * | 1983-07-13 | 1985-01-31 | Yakurigaku Chuo Kenkyusho:Kk | γ−アミノ酪酸又はその誘導体を主有効成分として含有する血管性頭痛及び二日酔治療薬 |
US5189064A (en) * | 1985-07-22 | 1993-02-23 | Matrix Technologies, Inc. | Treatment of cocaine addiction |
US5232917A (en) * | 1987-08-25 | 1993-08-03 | University Of Southern California | Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
US5120723A (en) * | 1987-08-25 | 1992-06-09 | University Of Southern California | Method, compositions, and compounds for modulating brain excitability |
ES2155543T3 (es) * | 1994-11-23 | 2001-05-16 | Cocensys Inc | Serie de androstano y pregnano para modulacion alosterica del receptor de gaba. |
-
1994
- 1994-11-18 US US08/342,090 patent/US5767117A/en not_active Expired - Fee Related
-
1995
- 1995-11-17 PT PT95942443T patent/PT789567E/pt unknown
- 1995-11-17 EP EP95942443A patent/EP0789567B1/en not_active Expired - Lifetime
- 1995-11-17 DE DE69535498T patent/DE69535498T2/de not_active Expired - Fee Related
- 1995-11-17 ES ES95942443T patent/ES2289745T3/es not_active Expired - Lifetime
- 1995-11-17 DK DK95942443T patent/DK0789567T3/da active
- 1995-11-17 WO PCT/US1995/015070 patent/WO1996015782A1/en active IP Right Grant
- 1995-11-17 EP EP07009614A patent/EP1839657A3/en not_active Withdrawn
- 1995-11-17 JP JP8517015A patent/JPH10509178A/ja active Pending
- 1995-11-17 AT AT95942443T patent/ATE362361T1/de not_active IP Right Cessation
- 1995-11-17 CA CA002205134A patent/CA2205134C/en not_active Expired - Fee Related
-
1998
- 1998-01-26 US US09/013,390 patent/US5929061A/en not_active Expired - Fee Related
-
2007
- 2007-08-16 JP JP2007212456A patent/JP2007291143A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0789567A1 (en) | 1997-08-20 |
US5767117A (en) | 1998-06-16 |
ES2289745T3 (es) | 2008-02-01 |
JP2007291143A (ja) | 2007-11-08 |
PT789567E (pt) | 2007-08-24 |
EP1839657A3 (en) | 2007-12-19 |
EP0789567B1 (en) | 2007-05-16 |
CA2205134A1 (en) | 1996-05-30 |
ATE362361T1 (de) | 2007-06-15 |
US5929061A (en) | 1999-07-27 |
EP0789567A4 (en) | 1999-01-13 |
EP1839657A2 (en) | 2007-10-03 |
CA2205134C (en) | 2008-08-19 |
WO1996015782A1 (en) | 1996-05-30 |
JPH10509178A (ja) | 1998-09-08 |
DE69535498D1 (de) | 2007-06-28 |
DE69535498T2 (de) | 2008-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0789567T3 (da) | En fremgangsmåde til behandling af vaskulære hovedpiner | |
DK0716857T3 (da) | Anvendelse af rapamycin til behandling af anæmi | |
CY1112425T1 (el) | Αντισωματα αντι-ngf για την θεραπευτικη αγωγη διαφορων διαταραχων | |
DK0971713T3 (da) | Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser | |
NL300180I2 (nl) | Toepasen van toxmoxetine voor het behandelen van de concentratiestoornis/hyperactiviteit aandoening. | |
EP1212088A4 (en) | METHOD FOR TREATING SYMPTOMS OF DISEASES OF THE CENTRAL NERVOUS SYSTEM | |
DK1039887T3 (da) | Anvendelse af aminothiolforbindelser til behandling af neuro- og nefrolidelser og terapeutiske toksiciteter | |
DK1492561T3 (da) | Fremgangsmåde til behandling af brystkirtellidelser | |
HU912359D0 (en) | The use of flupirtine active agents for treating muscle-tension | |
DE69433079D1 (de) | Verwendung von imidazole zur behandlung von krankheiten, die durch neovaskularisierung gekennzeichnet sind | |
DK0840601T3 (da) | THIP til behandling af søvnforstyrrelser | |
DE69929464D1 (de) | Zyklische polyamine zur behandlung der thrombozytopenie | |
ATE304855T1 (de) | Verwendung von olanzapin zur behandlung von mentalen erkrankungen verursacht durch zerebrovaskuläre erkrankungen | |
DK0655243T3 (da) | Melatoninderivater til anvendelse ved behandling af søvnlidelser | |
ATE239470T1 (de) | Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen | |
ATE175927T1 (de) | Verfahren zum verbessern von eisenbahnrädern | |
NO990436D0 (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
DK0517787T3 (da) | Fremgangsmåde til behandling af terapiresistent skizofreni med amperozide | |
DE60107516D1 (de) | Verwendung von Pregabalin zur Asthma Behandlung | |
DE69903931T2 (de) | Vorrichtung zur behandlung von wasser | |
NO984190L (no) | FremgangsmÕte for behandling av insomnia |